Literature DB >> 7427878

Granulomatous hepatitis as a late complication of BCG immunotherapy.

T Flippin, B Mukherji, Y Dayal.   

Abstract

A case of BCG-induced granulomatous hepatitis, which developed 1 1/2 years after BCG immunotherapy for recurrent malignant melanoma, is described to document the development of this disease entity as a potential late complication of BCG immunotherapy. The clinical implications of the late development of BCG-induced granulomatous hepatitis, use of immunosuppressive chemotherapy, and possible alternatives for BCG in intratumor immunotherapy are discussed.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7427878     DOI： 10.1002/1097-0142(19801015)46:8<1759::aid-cncr2820460810>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  4 in total

1.  A case of BCG sepsis with bone marrow and liver involvement after intravesical BCG instillation.

Authors:  B Dederke; E O Riecken; T Weinke
Journal:  Infection       Date:  1998 Jan-Feb       Impact factor: 3.553

2.  [Sepsis and multiple organ failure after BCG-instillation for bladder cancer].

Authors:  A Elmer; U Bermes; L Drath; E Büscher; A Viertel
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

3.  Hypotension and disseminated intravascular coagulation following intralesional bacillus Calmette-Guérin therapy for locally metastatic melanoma.

Authors:  M H Cohen; R J Elin; B J Cohen
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin.

Authors:  Aliye Soylu; Ali T Ince; Hakan Polat; Nurgul Yasar; Aydin Ciltas; Selvinaz Ozkara; Ali I Tasci
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-04-15       Impact factor: 3.944
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.